After stomping onto the public markets in January, Dr Martens is on the cusp of joining the FTSE 100. For a brand synonymous with youthful rebellion, it’s all embarrassingly mainstream. Can it keep pleasing the City and the disaffected youth?
Ever since the 1960s, when The Who’s Pete Townshend strode across the stage in a pair of DMs, the brand has somehow managed to appeal to the masses without shedding its rebellious roots in the eyes of consumers.
Its £672 million of annual sales come from around the world. Rapid vaccine rollouts in America and the UK — Dr Martens’ two biggest markets — have helped and boss Kenny Wilson, who owns a stake worth about £55 million, is chasing growth in Asia.
After floating
